Dolutegravir, Emtricitabine And Tenolovir Alafenamide Tablets

Get a Price/Quote

MOQ : 100 Packs

Dolutegravir, Emtricitabine And Tenolovir Alafenamide Tablets Specification

Salt Composition
Dolutegravir 50mg, Emtricitabine 200mg, Tenofovir Alafenamide 25mg

Dosage Form
Film-coated tablets

Indication
HIV-1 infection treatment in adults and adolescents

Enzyme Types
Not applicable (antiretroviral agents)

Feature
Once daily, fixed dose combination

Ingredients
Dolutegravir sodium, Emtricitabine, Tenofovir Alafenamide fumarate, excipients

Application
Oral administration for antiretroviral therapy

Physical Color/Texture
White to off-white, film-coated tablet

Fermentation Smell
Odorless or practically odorless

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
36 months from manufacturing date

Packing Size
30 tablets per bottle

Patient Population
Adults and adolescents (weight 35 kg)

Product Code
9611024

Route of Administration
Oral

Therapeutic Class
Antiretroviral, Integrase inhibitor, NRTIs

Disposal
Dispose of unused medicine as per local guidelines

Regulatory Status
WHO/USFDA approved molecules

Inactive Ingredients
Lactose monohydrate, microcrystalline cellulose, magnesium stearate, etc.

Warning/Precautions
Not to be used in children less than 12 years or weighing under 35 kg without consult; monitor renal function

Drug Interaction
May interact with rifampicin, carbamazepine, phenytoin etc.

Prescription Status
Prescription only

Dolutegravir, Emtricitabine And Tenolovir Alafenamide Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Dolutegravir, Emtricitabine And Tenolovir Alafenamide Tablets

Capitalise on the soaring demand for Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets-a trending and best-seller antiretroviral formulation! This potent, once-daily, fixed-dose combination is specifically designed for optimum HIV-1 treatment in adults and adolescents (35 kg) and leverages WHO/USFDA-approved molecules. Each film-coated tablet (packed 30 per bottle) ensures reliability, safety, and patient compliance. Prescription-only, its white to off-white, odorless composition offers convenience while strict essentials like renal function monitoring, drug interaction caution, and correct disposal make it a smart choice for healthcare professionals and suppliers alike.

Versatile Use and Oral Administration

These tablets are indicated exclusively for the treatment of HIV-1 infection in adults and adolescents weighing at least 35 kg. Designed for oral administration, this fixed-dose combination ensures convenient, once-daily usage for patients. Suitable only on prescription, its clear guidance and established therapeutic class provide assurance for both patients and clinicians. Application is straightforward: simply take by mouth with or without food, as directed by a healthcare provider, supporting adherence and effective antiretroviral therapy.

Efficient Supply, Packaging, and Delivery

Our Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets are readily available for dependable domestic market distribution and international dispatching. Each bottle is securely packaged with 30 film-coated tablets, ensuring product integrity during transport. Suppliers in India can benefit from rapid delivery timelines and sample availability upon request. Our streamlined supply process supports consistent inventory management, helping healthcare partners meet ongoing patient demand efficiently, while adhering to stringent regulatory and packaging standards.

FAQ's of Dolutegravir, Emtricitabine And Tenolovir Alafenamide Tablets:

Q: How should Dolutegravir, Emtricitabine and Tenofovir Alafenamide Tablets be administered?

A: These tablets should be taken orally, once daily, following your healthcare provider's instructions. They can be consumed with or without food.

Q: What is the main benefit of this fixed-dose combination for HIV-1 treatment?

A: The combination offers potent antiretroviral activity in a single, convenient tablet, improving adherence and simplifying therapy for adults and adolescents (weighing at least 35 kg).

Q: When should renal function be monitored during therapy?

A: Renal function should be monitored regularly during treatment, especially if other medications influencing kidney function are being used.

Q: Where should unused tablets be disposed of?

A: Unused tablets should be disposed of in accordance with local regulatory guidelines to ensure environmental safety.

Q: What are common drug interactions to be aware of with this medicine?

A: This medication may interact with drugs such as rifampicin, carbamazepine, and phenytoin. Always inform your healthcare provider about all medicines you are taking.

Q: How is the product supplied and what is the shelf life?

A: The product comes in bottles containing 30 film-coated tablets, with a shelf life of 36 months when stored below 30C, protected from moisture and light.

Tell us about your requirement